234 related articles for article (PubMed ID: 29503117)
1. Assessment of Heparin Anticoagulation Measured Using i-STAT and Hemochron Activated Clotting Time.
Maslow A; Chambers A; Cheves T; Sweeney J
J Cardiothorac Vasc Anesth; 2018 Aug; 32(4):1603-1608. PubMed ID: 29503117
[TBL] [Abstract][Full Text] [Related]
2. Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass.
Guzzetta NA; Monitz HG; Fernandez JD; Fazlollah TM; Knezevic A; Miller BE
Anesth Analg; 2010 Jul; 111(1):173-9. PubMed ID: 20519414
[TBL] [Abstract][Full Text] [Related]
3. A Pilot Study to Assess the Clinical Onset of IV Heparin in Interventional Cardiology and Cardiac Surgery.
Asher S; Maslow A; Mishra V; Flaherty D; Hayward G; Whiteneck S; Cheves T; Sweeney J
J Cardiothorac Vasc Anesth; 2022 Dec; 36(12):4281-4288. PubMed ID: 36100498
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Point-of-Care ACT Coagulometers and Anti-Xa Activity During Cardiopulmonary Bypass.
Falter F; MacDonald S; Matthews C; Kemna E; Cañameres J; Besser M
J Cardiothorac Vasc Anesth; 2020 Nov; 34(11):2921-2927. PubMed ID: 32620484
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulation monitoring during vascular surgery: accuracy of the Hemochron low range activated clotting time (ACT-LR).
Tremey B; Szekely B; Schlumberger S; François D; Liu N; Sievert K; Fischler M
Br J Anaesth; 2006 Oct; 97(4):453-9. PubMed ID: 16873382
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a new point-of-care celite-activated clotting time analyzer in different clinical settings. The i-STAT celite-activated clotting time test.
Paniccia R; Fedi S; Carbonetto F; Noferi D; Conti P; Bandinelli B; Giusti B; Evangelisti L; Pretelli P; Palmarini MF; Abbate R; Prisco D
Anesthesiology; 2003 Jul; 99(1):54-9. PubMed ID: 12826842
[TBL] [Abstract][Full Text] [Related]
7. Point-of-care measurement of activated clotting time for cardiac surgery as measured by the Hemochron signature elite and the Abbott i-STAT: agreement, concordance, and clinical reliability.
Dirkmann D; Nagy E; Britten MW; Peters J
BMC Anesthesiol; 2019 Sep; 19(1):174. PubMed ID: 31492108
[TBL] [Abstract][Full Text] [Related]
8. Comparison between activated clotting time and anti-activated factor X activity for the monitoring of unfractionated heparin therapy in patients with aortic aneurysm undergoing an endovascular procedure.
Dieplinger B; Egger M; Luft C; Hinterreiter F; Pernerstorfer T; Haltmayer M; Mueller T
J Vasc Surg; 2018 Aug; 68(2):400-407. PubMed ID: 29571622
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative Monitoring of Heparin: Comparison of Activated Coagulation Time and Whole Blood Heparin Measurements by Different Point-of-Care Devices with Heparin Concentration by Laboratory-Performed Plasma Anti-Xa Assay.
Thompson TZ; Kunak RL; Savage NM; Agarwal S; Chazelle J; Singh G
Lab Med; 2019 Oct; 50(4):348-356. PubMed ID: 31053856
[TBL] [Abstract][Full Text] [Related]
10. Comparison of activated clotting times obtained using Hemochron and Medtronic analysers in patients receiving anti-thrombin therapy during cardiac catheterisation.
Chia S; Van Cott EM; Raffel OC; Jang IK
Thromb Haemost; 2009 Mar; 101(3):535-40. PubMed ID: 19277416
[TBL] [Abstract][Full Text] [Related]
11. The effects of MDCO-2010, a serine protease inhibitor, on activated clotting time in blood obtained from volunteers and cardiac surgical patients.
Kim H; Szlam F; Tanaka KA; van de Locht A; Ogawa S; Levy JH
Anesth Analg; 2012 Aug; 115(2):244-52. PubMed ID: 22584552
[TBL] [Abstract][Full Text] [Related]
12. The activated coagulation time: suitability for monitoring heparin effect and neutralization during pediatric cardiac surgery.
Martindale SJ; Shayevitz JR; D'Errico C
J Cardiothorac Vasc Anesth; 1996 Jun; 10(4):458-63. PubMed ID: 8776637
[TBL] [Abstract][Full Text] [Related]
13. Activated Clotting Time (ACT) for Monitoring of Low-Dose Heparin: Performance Characteristics in Healthy Adults and Critically Ill Patients.
Wehner JE; Boehne M; David S; Brand K; Tiede A; Bikker R
Clin Appl Thromb Hemost; 2020; 26():1076029620975494. PubMed ID: 33350327
[TBL] [Abstract][Full Text] [Related]
14. Influence of different anticoagulant agents on fibrinopeptide a generation.
Tobu M; Iqbal O; Messmore HL; Ma Q; Hoppensteadt DA; Fareed J
Clin Appl Thromb Hemost; 2003 Oct; 9(4):273-92. PubMed ID: 14653437
[TBL] [Abstract][Full Text] [Related]
15. Heparin monitoring during cardiopulmonary bypass surgery using the one-step point-of-care whole blood anti-factor-Xa clotting assay heptest-POC-Hi.
Hellstern P; Bach J; Simon M; Saggau W
J Extra Corpor Technol; 2007 Jun; 39(2):81-6. PubMed ID: 17672188
[TBL] [Abstract][Full Text] [Related]
16. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
[TBL] [Abstract][Full Text] [Related]
17. Kaolin-based activated coagulation time measured by sonoclot in patients undergoing cardiopulmonary bypass.
Ganter MT; Monn A; Tavakoli R; Klaghofer R; Zollinger A; Hofer CK
J Cardiothorac Vasc Anesth; 2007 Aug; 21(4):524-8. PubMed ID: 17678778
[TBL] [Abstract][Full Text] [Related]
18. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
[TBL] [Abstract][Full Text] [Related]
19. Clinical Evaluation of Measuring the ACT during Elective Cardiac Surgery with Two Different Devices.
Falter F; Razzaq N; John M; Fassl J; Maurer M; Ewing S; Hofmeyr R
J Extra Corpor Technol; 2018 Mar; 50(1):38-43. PubMed ID: 29559753
[TBL] [Abstract][Full Text] [Related]
20. Correlation of ACT as measured with three commercially available devices with circulating heparin level during cardiac surgery.
Niles SD; Sutton RG; Ploessl J; Pennell B
J Extra Corpor Technol; 1995 Dec; 27(4):197-200. PubMed ID: 10172651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
